two new protease inhibitors for chronic hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir)

You'll see two new protease inhibitors for chronic hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir).

That's right...protease inhibitors for hep C.

These are "game changers" because they offer a much higher cure rate when added to pegylated interferon and ribavirin for hep C. They can also shorten treatment duration.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote